Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Novel nicotinic ligand discovered by British university researchers

Dec. 22, 1997

Pharmacological characterization of LY-344864, a selective 5-HT1F receptor agonist

Dec. 22, 1997

Prevention of neurodegeneration in Parkinson's disease reported

Dec. 22, 1997

Naramig available in Germany

Dec. 19, 1997

European approvals for Edronax

Dec. 19, 1997

Patient accrual in Cerestat trials will not resume

Dec. 19, 1997

Synthelabo to market milnacipran in Europe and certain other markets

Dec. 19, 1997

Bayer develops compounds for neurodegenerative disorders

Dec. 19, 1997

Animal study indicates potential of GAT inhibitors for anxiety

Dec. 18, 1997

Behavioral effects of novel mGluR agonist in rats

Dec. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...